Investor Relations
Aspira Women's Health
Company Overview
Aspira Women’s Health is led by an experienced team of business, medical and scientific professionals with a passion for improving health outcomes for women.
Aspira Women’s Health is helping transform women’s health with the discovery, development, and utilization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. Our FDA-cleared products Ova1® and Overa® detect the risk of ovarian malignancy in women with adnexal masses. With over 10 years of experience in ovarian cancer risk assessment, Aspira Women’s Health has expertise in cutting-edge research to inform our next generation of products. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection and optimize treatment plans.
Email Alerts
Click the button below to sign up for alerts on the latest news and updates from Aspira Women's Health, straight to your inbox.
Contact IR
Investor Relations